New Fluorescent Nucleic Acid Gel Stain is a Highly Sensitive Ethidium Bromide Alternative

Microscopy & microtechniques

New Fluorescent Nucleic Acid Gel Stain is a Highly Sensitive Ethidium Bromide Alternative

13 Feb, 2006

Published over 20 years ago. See the latest and most current information on Microscopy & microtechniques.

A new highly sensitive and robust nucleic acid gel stain has been introduced by Cambridge Bioscience. GelRed?, developed by Biotium, is a red fluorescent nucleic acid dye designed for both precast and post gel staining. Its combination of low toxicity, extraordinary stability, versatility and sensitivity (even for low molecular weight DNA fragments) sets it apart from all other nucleic acid stains on the market.

GelRed offers an excellent alternative to the widely used ethidium bromide (EB) stain, which is not only highly mutagenic but often requires a destaining step to reduce background fluorescence. GelRed is highly stable so, when used as a precast gel stain, it can be microwaved with agarose or subjected to other heating procedures commonly used in gel preparation. Importantly, gels can also be safely and conveniently stored for later use without compromising performance.

The GelRed dye has a major excitation peak at around 300 nm and a red emission at around 595 nm meaning it can be optimally excited with a standard 300 nm UV transilluminator while its fluorescence emission is completely compatible with a standard EB filter or SYBR filter.

Latest News

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
World Bank commits USD600m to clean air programmes in Uttar Pradesh and Haryana
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow